|
Name |
Cladospolide A
|
| Molecular Formula | C12H20O4 | |
| IUPAC Name* |
(3E,5R,6S,12R)-5,6-dihydroxy-12-methyl-1-oxacyclododec-3-en-2-one
|
|
| SMILES |
C[C@@H]1CCCCC[C@@H]([C@@H](/C=C/C(=O)O1)O)O
|
|
| InChI |
InChI=1S/C12H20O4/c1-9-5-3-2-4-6-10(13)11(14)7-8-12(15)16-9/h7-11,13-14H,2-6H2,1H3/b8-7+/t9-,10+,11-/m1/s1
|
|
| InChIKey |
PLHJPQNLCWFPFY-OUZGJDHNSA-N
|
|
| Synonyms |
Cladospolide A; (-)-Cladospolide A; 77663-54-8; 73G9U1L1XD; (3E,5R,6S,12R)-5,6-dihydroxy-12-methyl-1-oxacyclododec-3-en-2-one; UNII-73G9U1L1XD; 5-EPI-CLADOSPOLIDE C; (3E,5R,6S,12R)-5,6-Dihydroxy-12-methyloxacyclododec-3-en-2-one; CLADOSPOLIDE A, (-)-; Oxacyclododec-3-en-2-one, 5,6-dihydroxy-12-methyl-, (3E,5R,6S,12R)-; Q27896692; (4R,5S,11R,2E)-4,5-DIHYDROXY-2-DODECEN-11-OLIDE; OXACYCLODODEC-3-EN-2-ONE, 5,6-DIHYDROXY-12-METHYL-, (5R-(3E,5R*,6S*,12R*))-
|
|
| CAS | 77663-54-8 | |
| PubChem CID | 11020642 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 228.28 | ALogp: | 1.4 |
| HBD: | 2 | HBA: | 4 |
| Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 66.8 | Aromatic Rings: | 1 |
| Heavy Atoms: | 16 | QED Weighted: | 0.618 |
| Caco-2 Permeability: | -4.61 | MDCK Permeability: | 0.00005230 |
| Pgp-inhibitor: | 0.964 | Pgp-substrate: | 0.015 |
| Human Intestinal Absorption (HIA): | 0.01 | 20% Bioavailability (F20%): | 0.036 |
| 30% Bioavailability (F30%): | 0.645 |
| Blood-Brain-Barrier Penetration (BBB): | 0.98 | Plasma Protein Binding (PPB): | 65.58% |
| Volume Distribution (VD): | 0.355 | Fu: | 48.28% |
| CYP1A2-inhibitor: | 0.02 | CYP1A2-substrate: | 0.456 |
| CYP2C19-inhibitor: | 0.113 | CYP2C19-substrate: | 0.811 |
| CYP2C9-inhibitor: | 0.044 | CYP2C9-substrate: | 0.289 |
| CYP2D6-inhibitor: | 0.008 | CYP2D6-substrate: | 0.128 |
| CYP3A4-inhibitor: | 0.016 | CYP3A4-substrate: | 0.179 |
| Clearance (CL): | 10.903 | Half-life (T1/2): | 0.706 |
| hERG Blockers: | 0.021 | Human Hepatotoxicity (H-HT): | 0.258 |
| Drug-inuced Liver Injury (DILI): | 0.405 | AMES Toxicity: | 0.947 |
| Rat Oral Acute Toxicity: | 0.078 | Maximum Recommended Daily Dose: | 0.471 |
| Skin Sensitization: | 0.925 | Carcinogencity: | 0.547 |
| Eye Corrosion: | 0.183 | Eye Irritation: | 0.913 |
| Respiratory Toxicity: | 0.565 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002200 | ![]() |
1.000 | D07GRH | ![]() |
0.323 | ||
| ENC004377 | ![]() |
0.679 | D04URO | ![]() |
0.273 | ||
| ENC003404 | ![]() |
0.679 | D03DVJ | ![]() |
0.250 | ||
| ENC004602 | ![]() |
0.563 | D08MRN | ![]() |
0.238 | ||
| ENC004599 | ![]() |
0.563 | D0P6VV | ![]() |
0.234 | ||
| ENC003186 | ![]() |
0.521 | D0N4PZ | ![]() |
0.230 | ||
| ENC006036 | ![]() |
0.521 | D0Z1FX | ![]() |
0.226 | ||
| ENC001414 | ![]() |
0.516 | D0D1SG | ![]() |
0.223 | ||
| ENC003460 | ![]() |
0.515 | D07WFK | ![]() |
0.221 | ||
| ENC003784 | ![]() |
0.515 | D0L9ZR | ![]() |
0.220 | ||